Illustrative packaging · Research use only
Tissue repair & growth axis
CJC-1295 with DAC
Choose a specification
1 pack · 10 vials total
Guest checkout is available. Create an account before your first request to receive the eligible 10% welcome offer.
Choose your payment method at checkout to see the total and next payment steps. No administration or personal-use guidance is provided.
Randomized human pharmacology trials
What the research examines
CJC-1295 was evaluated as a long-acting GHRH analogue in randomized, placebo-controlled studies. Researchers measured pharmacokinetic exposure and GH/IGF-I responses over time.
Potential research applications
Research topics include the relationship between albumin-binding modification, persistence and endocrine response profiles.
These are research questions drawn from the cited work, not established applications of this supplied material.
Evidence limits
The clinical material was the long-acting derivative. Its findings cannot be transferred to a no-DAC listing or used to authenticate this vial.
Material identity and presentation
Powder vial artwork is conceptual; actual form and packaging unverified. Published findings do not establish the identity, purity or performance of an individual supplied material.
